|Articles|July 2, 2023
- Pharmaceutical Executive: July 2023
- Volume 43
- Issue 7
Pharmaceutical Executive, July 2023 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Executive June 2023 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 3 years ago
Crossing the Brain Barrieralmost 3 years ago
Biotech’s Survival Story: Companies Bear Down for Lean Yearsalmost 3 years ago
Harnessing AI for Pharma Salesalmost 3 years ago
Tapping New and Improved Drug Innovations in Asiaalmost 3 years ago
Drug Shortages Continue to Plague FDA, Manufacturersalmost 3 years ago
Contrasting Aims Highlight Pharma Reform Pursuitsalmost 3 years ago
Shifting Macro Trends Offer Hope for Biotech Performance Boostalmost 3 years ago
‘Bolus’ Markets: Unique Business Opportunities with Promise and RiskNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Eli Lilly’s Oral Weight Loss Pill Prescribed Over 1,000 Times in First Days on Market
2
Inside Pharma's Revenue Engine: The Gross-to-Net Reckoning
3
The Turning Point for Oral Biologics: Q&A With Morten Graugaard
4
Positioning A New Standard of Care in Relapsed Multiple Myeloma: Q&A with Imran Khan, MD, PhD
5

